Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive
Tempus AI has agreed to acquire cancer genomics partner Personalis for $1.5 billion, though the deal triggered a decline in share prices for both companies.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Tempus AI is acquiring Personalis, a maker of cancer tests, in a deal valued at $1.5 billion. The acquisition aims to more tightly integrate Molecular Residual Disease (MRD) into the existing AI-enabled precision oncology platform of Tempus.
Coverage from Reuters, Fierce Biotech, and Business Wire emphasizes the strategic integration of genomics and AI. Meanwhile, financial outlets including Barron's and Investor's Business Daily highlight a negative market reaction, noting that shares for both companies sank following the announcement.
Future developments depend on the completion of the buyout and the subsequent integration of Personalis's MRD capabilities into the Tempus platform.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 6h ago.
Quick answers
How much is Tempus AI paying for Personalis?
The acquisition is valued at $1.5 billion.
What is the primary technical goal of the acquisition?
Tempus aims to integrate Molecular Residual Disease (MRD) into its AI-enabled precision oncology platform.
How did the stock market respond to the news?
According to Barron's and Investor's Business Daily, shares for both Tempus AI and Personalis dove or sank.
Coverage (5)
- Tempus buys out cancer genomics partner Personalis in $1.5 billion deal Fierce Biotech · 15h ago
- Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform Business Wire · 15h ago
- Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink Barron's · 15h ago
- Tempus to buy cancer test maker Personalis for $1.5 billion Reuters · 15h ago
- Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive Investor's Business Daily · 15h ago
Topics
Related trends
The U.S. Is Pulling Back on Energy Efficiency Just as Prices Are Rising
The U.S. Department of Energy is proposing changes to energy conservation standards amid a period of rising prices.
Miami's cost of living now tops New York City's despite Florida's tax advantages
New US data reveals that Miami's cost of living has surpassed that of New York City for the first time ever.
GM beats on earnings, raises guidance amid resilient vehicle pricing
General Motors has raised its 2026 outlook following a Q2 earnings beat driven by premium truck pricing and reduced costs.